NM_001375405.1:c.1684A>G

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting

The NM_001375405.1(CEP120):​c.1684A>G​(p.Thr562Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000379 in 1,613,064 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T562S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00027 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00039 ( 0 hom. )

Consequence

CEP120
NM_001375405.1 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 4.81
Variant links:
Genes affected
CEP120 (HGNC:26690): (centrosomal protein 120) This gene encodes a protein that functions in the microtubule-dependent coupling of the nucleus and the centrosome. A similar protein in mouse plays a role in both interkinetic nuclear migration, which is a characteristic pattern of nuclear movement in neural progenitors, and in neural progenitor self-renewal. Mutations in this gene are predicted to result in neurogenic defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.04665774).
BS1
Variant frequency is greater than expected in population amr. gnomad4_exome allele frequency = 0.00039 (570/1461442) while in subpopulation AMR AF= 0.000828 (37/44670). AF 95% confidence interval is 0.000617. There are 0 homozygotes in gnomad4_exome. There are 285 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP120NM_001375405.1 linkc.1684A>G p.Thr562Ala missense_variant Exon 11 of 20 ENST00000306467.10 NP_001362334.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP120ENST00000306467.10 linkc.1684A>G p.Thr562Ala missense_variant Exon 11 of 20 5 NM_001375405.1 ENSP00000303058.6 Q8N960-1

Frequencies

GnomAD3 genomes
AF:
0.000271
AC:
41
AN:
151504
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000194
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000527
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000368
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000339
AC:
85
AN:
251052
Hom.:
0
AF XY:
0.000346
AC XY:
47
AN XY:
135690
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.000784
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000431
Gnomad OTH exome
AF:
0.000818
GnomAD4 exome
AF:
0.000390
AC:
570
AN:
1461442
Hom.:
0
Cov.:
31
AF XY:
0.000392
AC XY:
285
AN XY:
727028
show subpopulations
Gnomad4 AFR exome
AF:
0.000179
Gnomad4 AMR exome
AF:
0.000828
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.000447
Gnomad4 OTH exome
AF:
0.000464
GnomAD4 genome
AF:
0.000270
AC:
41
AN:
151622
Hom.:
0
Cov.:
32
AF XY:
0.000202
AC XY:
15
AN XY:
74080
show subpopulations
Gnomad4 AFR
AF:
0.000194
Gnomad4 AMR
AF:
0.000526
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000368
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000412
Hom.:
1
Bravo
AF:
0.000302
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.000198
AC:
24
EpiCase
AF:
0.000273
EpiControl
AF:
0.000534

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
May 13, 2021
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.1684A>G (p.T562A) alteration is located in exon 12 (coding exon 11) of the CEP120 gene. This alteration results from a A to G substitution at nucleotide position 1684, causing the threonine (T) at amino acid position 562 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Short-rib thoracic dysplasia 13 with or without polydactyly;C4540355:Joubert syndrome 31 Uncertain:1
Feb 28, 2023
Clinical Genomics Laboratory, Stanford Medicine
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Uncertain:1
Jul 25, 2024
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Short-rib thoracic dysplasia 13 with or without polydactyly Uncertain:1
Jan 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 562 of the CEP120 protein (p.Thr562Ala). This variant is present in population databases (rs147277049, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with CEP120-related conditions. ClinVar contains an entry for this variant (Variation ID: 577784). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CEP120 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.041
T;T;.;T
Eigen
Benign
-0.014
Eigen_PC
Benign
0.18
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.76
.;T;T;T
M_CAP
Benign
0.0085
T
MetaRNN
Benign
0.047
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.6
L;L;.;.
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-1.5
N;N;N;N
REVEL
Benign
0.045
Sift
Benign
0.29
T;T;T;T
Sift4G
Benign
0.59
T;T;T;T
Polyphen
0.028
B;B;.;.
Vest4
0.29
MVP
0.40
MPC
0.073
ClinPred
0.017
T
GERP RS
5.6
Varity_R
0.23
gMVP
0.33

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs147277049; hg19: chr5-122720724; API